Classification and Management of Hyperkalemia

Diagnosis and Classification

The American Heart Association and the European Society of Cardiology classify hyperkalemia into three categories: mild (5.5-6.4 mmol/L), moderate (6.5-8.0 mmol/L), and severe (>8.0 mmol/L), which is crucial for guiding urgent treatment and preventing fatal cardiac arrhythmias 1, 2, 3
Serum potassium levels of 5.5-6.4 mmol/L are considered mild hyperkalemia, with electrocardiographic changes typically not manifesting until levels exceed 6.5 mmol/L 1, 2
Peaked T waves may appear in the range of 5.5-6.5 mmol/L 1, 2

The European Society of Cardiology recommends hospitalization for severe hyperkalemia (>6.0 mEq/L) regardless of symptoms, and for any level of potassium with electrocardiographic changes 4
Patients with high-risk comorbidities, such as advanced chronic kidney disease, heart failure, or diabetes mellitus, should be hospitalized 4
Hyperkalemia occurs less frequently than hypokalemia but represents a well-known challenge, mainly in patients with renal dysfunction 1, 2

The European Heart Journal recommends stabilizing cardiac membranes with calcium chloride or gluconate IV for immediate effect in severe hyperkalemia 3, 4
Shifting potassium intracellularly with insulin and glucose, beta-2 agonists, or sodium bicarbonate has effects within 30-60 minutes 3, 4
Eliminating potassium with loop diuretics, potassium binders, or hemodialysis is also recommended 3, 4

Continuous electrocardiographic monitoring is indicated in hospitalized patients with moderate and severe potassium imbalances to facilitate the use of published algorithms and prevent or intervene in lethal cardiac rhythms 1, 2
If a 12-lead ECG demonstrates electrical abnormalities in less severe electrolyte disturbances, continuous monitoring of arrhythmias should be considered 1, 2